Back to Stock Database
Split Ratio
1:20
Fractional Policy
Round Up ✓
Profit Potential
$7.60
Effective Date
2024-07-31
Current Price
$0.40
Post-Split Price
$8.00

How This Trade Works

Here's a step-by-step breakdown of how the BDRX reverse split arbitrage works using Biodexa Pharmaceuticals's actual numbers.

1

Buy 19 shares of BDRX

Purchase 19 shares at $0.40 each. Total cost: $7.60. You need exactly 19 shares because the split ratio is 1:20.

2

The 1:20 reverse split executes

Your 19 shares are consolidated at the 1:20 ratio. Since 19 ÷ 20 = 0.9500, you end up with a fractional share of 0.9500 post-split shares.

3

Fractional share rounds up to 1 full share

Because Biodexa Pharmaceuticals rounds up fractional shares, your 0.9500 shares become 1 full share worth $8.00.

4

Sell for profit

Sell your 1 post-split share at $8.00. You paid $7.60 and received $8.00.

$0.40
Profit per position (5% ROI)

Risk Factors

⚠

Penny Stock Volatility

BDRX trades at $0.40 per share, classifying it as a penny stock. Penny stocks are subject to extreme price swings, low institutional coverage, and higher spreads. The share price could drop significantly between your purchase and the split execution date.

⚠

Liquidity Risk

At $0.40 per share, BDRX may have limited trading volume and wide bid-ask spreads. This can make it difficult to enter or exit your position at your desired price, potentially reducing your actual profit.

ℹ

Split Already Completed

This reverse split was completed on 2024-07-31. The information here is for educational purposes and historical reference. This specific trade can no longer be executed.

⚠

Broker Policy Changes

Brokers may change their fractional share rounding policies at any time. Always verify your broker's current policy before placing an RSA trade. What worked for previous splits may not apply to future ones.

Broker Fractional Share Policies

For BDRX's 1:20 reverse split, Robinhood rounds up fractional shares — making it the preferred broker for this trade. Other brokers cash out the fractional portion, which means you'd receive a small cash payment instead of a full share.

Robinhood Rounds Up ✓
Interactive Brokers Cash Out
TD Ameritrade Cash Out
Charles Schwab Cash Out

Frequently Asked Questions

What is the BDRX reverse stock split ratio?
Biodexa Pharmaceuticals executed a 1:20 reverse stock split on 2024-07-31. This means every 20 pre-split shares are consolidated into 1 post-split share, raising the per-share price from $0.40 to $8.00.
Does BDRX round up fractional shares?
Yes. Biodexa Pharmaceuticals's fractional share policy rounds up, meaning if you hold any fractional share amount after the split, your broker will round it up to a full share. This is what creates the RSA profit opportunity.
How much profit can you make from the BDRX reverse split?
By purchasing 19 shares at $0.40 each (total cost: $7.60), the 1:20 split converts them into a fractional share that rounds up to 1 full share worth $8.00. That's a profit of $0.40 per position, or roughly 5% ROI.
Which brokers round up fractional shares for BDRX?
Robinhood rounds up fractional shares for BDRX, making it the preferred broker for this RSA trade. Interactive Brokers, TD Ameritrade, and Charles Schwab typically cash out fractional shares instead. Always verify your broker's current fractional share policy before placing a trade.
Is the BDRX reverse split still tradeable?
The BDRX reverse split is completed (effective date: 2024-07-31). While this specific opportunity has passed, TradeLabs continuously monitors the market for new reverse split arbitrage opportunities with similar characteristics.

Similar Reverse Splits

AYRO
AYRO Inc
1:20 Split $7.60
HTCO
High-Trend International Group
1:25 Split $7.75
OGEN
Oragenics Inc
1:25 Split $8.75

Automate Your RSA Trades

TradeLabs automatically finds, analyzes, and executes reverse split arbitrage trades across your brokers — so you never miss an opportunity like BDRX.

Get Early Access →